SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single ...
Read More »SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System
WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC today announced the launch of the tSMS System Early Access Program giving researchers priority access to its proprietary quantitative sequencing platform. This benchtop system has been designed to deliver unparalleled quantitative RNA and specialty DNA sequencing ...
Read More »